Heart Failure and Cardiomyopathies: From Accurate Diagnosis to Novel Therapies
This special issue belongs to the section "Clinical Diagnosis and Prognosis".
Special Issue Information
Dear Colleagues,
The prevalence of heart failure is steadily increasing, ringing alarms for an emerging epidemic that is not only associated with unpromising patient prognosis but also imposes a huge economic burden on healthcare systems worldwide. Although left ventricular ejection fraction remains the cornerstone of contemporary heart failure classification and therapeutic decision-making, accurate determination of the underlying etiology remains pivotal to ensure guideline-directed management and to enable the implementation of etiology-specific and targeted therapeutic strategies when indicated.
In this Special Issue, we will cover the entire spectrum of heart failure, irrespective of left ventricular ejection fraction, with a particular focus on the broad and continuously evolving field of cardiomyopathies across all phenotypes and etiologies.
Emphasis will be placed on recent advances and emerging concepts in diagnostics, risk stratification, prognostics, and therapeutic management of distinct cardiomyopathies, including—but not limited—to ischemic, dilated, restrictive, arrhythmogenic, and chemotherapy-induced forms.
Original articles, narrative reviews, and systematic reviews/meta-analyses are welcome.
Dr. Christos A. Papanastasiou
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the Special Issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heart failure
- cardiomyopathy
- diagnosis
- prognosis
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

